Healthcare Sales & Marketing Network News: trans sodium crocetinate

Searching News Database: trans sodium crocetinate

HSMN NewsFeed - 11 Dec 2012
Diffusion Pharmaceuticals Receives FDA Orphan Designation for TSC, a First-in-Class Drug for the Treatment of Metastatic Brain Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 26 Jul 2011
Diffusion Pharmaceuticals Receives FDA Orphan Status for TSC, a First-in-Class Drug for the Treatment of Primary Brain Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 29 Jan 2010
Diffusion Pharmaceuticals LLC Closes on $5.9 Million Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 26 Apr 2007
Diffusion Pharmaceuticals Announces Formation of Scientific Advisory Board Chaired by Company Co-founder, John L. Gainer, Ph.D.
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Mar 2007
Diffusion Pharmaceuticals Initiates Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC)
Biopharmaceuticals

HSMN NewsFeed - 14 Nov 2006
Diffusion Pharmaceuticals Strengthens Management Team With Appointment of Matthew W. Hantzmon as Vice President, Business Development
Biopharmaceuticals Personnel

Return to NewsFeed

Additional items found! 1

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 1 additional stories matching:
trans sodium crocetinate
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.